The number of teens and young adults taking GLP-1 drugs has increased by 594 percent—but scientists are still trying to ...
Hims & Hers stock drops 26% as FDA resolves semaglutide shortage, threatening GLP-1 revenue. Click here to find out why HIMS ...
The MHRA reveals a staggering rise in deaths linked to weight loss and diabetes medications in the UK, with concerns over ...
We recently published an article titled Two of 10 Worst-Performing Stocks Fall to All-Time Lows on Tuesday. In this article, ...
People with a high body weight living in England can now access subsidized weight-loss drugs to treat their obesity. This ...
Drug compounders aren’t ready to give up their ability to produce off-brand versions of Novo Nordisk’s weight-loss drug ...
It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Recent research found that weight loss drugs like Ozempic may be contributing to a national trend of thyroid cancer ...
When I’m taking [the medicine], I tend to hold a lot of water weight, and that happens very normally. And then when I’m off of it, I tend to kind of lose weight,” the actress said in 2023.
Elon Musk wants to cut funding for scientific research, but the weight loss drugs he promoted also came from government funded basic science.